793044 | C16 Ceramide (d18:1(D7)/16:0(13C16))
N-palmitoyl(13C16))-D-erythro-sphingosine(d18:1(D7))
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Info
C16 Ceramide (d18:1(D7)/16:0(13C16))
N-palmitoyl(13C16))-D-erythro-sphingosine(d18:1(D7))
| Monitoring the levels of the ceramides (Cer) d18:1/16:0 and ratios thereof in human plasma empowers the prediction of fatal outcome of coronary artery disease. Avanti has now made available these ceramides in a stable isotope form as a convenience for a newly described validated liquid chromatography-tandem mass spectrometry methodology for their clinical-scaled measurement. This product is deuterated which will enable the study of structure, dynamics, and function of this lipid within the cell. Refer: D. Kauhanen et al. (2016). Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides. Anal Bioanal Chem 408:3475-83 |
Data
No
No
| C1813C16H60D7NO3 |
>99%
1 year
-20°C
560.83
560.61
Powered by Bioz
